Chemsol Labs Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 10-12-2024
- Paid Up Capital ₹ 3.00 Cr
as on 10-12-2024
- Company Age 18 Year, 4 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 8.70 Cr
as on 10-12-2024
- Satisfied Charges ₹ 10.25 Cr
as on 10-12-2024
- Revenue -4.30%
(FY 2016)
- Profit -19.61%
(FY 2016)
- Ebitda -3.31%
(FY 2016)
- Net Worth 4.83%
(FY 2016)
- Total Assets 17.13%
(FY 2016)
About Chemsol Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹8.70 Cr. The company has closed loans amounting to ₹10.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vemula Krishna and Vemula Kumari serve as directors at the Company.
- CIN/LLPIN
U24299TG2006PTC050960
- Company No.
050960
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 2006
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Chemsol Labs Private Limited offer?
Chemsol Labs Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, Digestive System Drugs & Medicines, Antacid Drugs, Organic and Inorganic Solvents, Alcohol Solvents, Chemical Intermediates, Formic Acid, API (Active Pharmaceutical Ingredients), Pharmaceutical Pellets.
Who are the key members and board of directors at Chemsol Labs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vemula Krishna  | Additional Director | 01-Apr-2017 | Current |
| Vemula Kumari | Additional Director | 01-Apr-2017 | Current |
Financial Performance of Chemsol Labs.
Chemsol Labs Private Limited, for the financial year ended 2016, experienced Minor drop in revenue, with a 4.3% decrease. The company also saw a substantial fall in profitability, with a 19.61% decrease in profit. The company's net worth moved up by a moderate rise of 4.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemsol Labs?
In 2015, Chemsol Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Nov 2015 | ₹8.70 Cr | Open |
Standard Chartered Bank Creation Date: 30 Jun 2015 | ₹2.50 M | Satisfied |
Standard Chartered Bank Creation Date: 19 Nov 2012 | ₹6.00 Cr | Satisfied |
How Many Employees Work at Chemsol Labs?
Unlock and access historical data on people associated with Chemsol Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemsol Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemsol Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
